glycyrrhizic acid has been researched along with Aberrant Crypt Foci in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, F; Hamiza, OO; Khan, AQ; Khan, R; Lateef, A; Rehman, MU; Sultana, S; Tahir, M | 1 |
1 other study(ies) available for glycyrrhizic acid and Aberrant Crypt Foci
| Article | Year |
|---|---|
Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats.
Topics: Aberrant Crypt Foci; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Colon; Colorectal Neoplasms; Connexin 43; Dimethylhydrazines; Glycyrrhizic Acid; Male; Mast Cells; Mucins; Rats; Rats, Wistar; Sialomucins; Tumor Necrosis Factor-alpha | 2013 |